AstraZeneca PLC 2011 AR2
The report highlights AstraZeneca's financial and operational performance in 2011, emphasizing its commitment to delivering innovative medicines responsibly. Key achievements include the launch of a new Responsible Business Plan and the creation of a Responsible Business Council to strengthen ESG governance. The company achieved its highest-ever score of 85% in the Dow Jones Sustainability Index, ranking in the top 7% of its sector. Additionally, AstraZeneca expanded its responsible procurement audit program to 751 audits of 727 suppliers and invested in community programs, including the global Young Health Programme.
Company: AstraZeneca PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2011
Type: AR2
Pages: 216
Back to company
AstraZeneca PLC
Annual Report And Form 20-F Information
The report highlights AstraZeneca's financial and operational performance in 2011, emphasizing its commitment to delivering innovative medicines responsibly. Key achievements include the launch of a new Responsible Business Plan and the creation of a Responsible Business Council to strengthen ESG governance. The company achieved its highest-ever score of 85% in the Dow Jones Sustainability Index, ranking in the top 7% of its sector. Additionally, AstraZeneca expanded its responsible procurement audit program to 751 audits of 727 suppliers and invested in community programs, including the global Young Health Programme.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2011
Reporting Period
Jan 1, 2011 - Dec 31, 2011
Fiscal Year
2011
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Total Waste
Workplace Fatalities
Employees